Reinhard Ambros

Photo of Reinhard Ambros, Novartis Venture Funds
CompanyDeal TypeAmountDate
ImmunOs TherapeuticsSeries ACHF15MDec 2019
Aileron TherapeuticsSeries E$33MOct 2014
Aileron TherapeuticsSeries E$30MNov 2013
Aileron TherapeuticsSeries D$12MJan 2013
FORMA TherapeuticsSeries B$3MDec 2009
FORMA TherapeuticsSeries B$25.5MDec 2009
Aileron TherapeuticsSeries D$40MJun 2009
Aileron TherapeuticsSeries C$10.5MApr 2008
FORMA TherapeuticsSeries A$4M (Lead)Apr 2008
Aileron TherapeuticsSeries B$7MJun 2007
No media found for Reinhard Ambros.
cb
Photo of Anja Konig, Managing Director at Novartis Venture Funds

Novartis Venture Funds

Photo of Beat Steffen, Principal at Novartis Venture Funds

Novartis Venture Funds

Photo of Campbell Murray, Managing Director at Novartis Venture Funds

Novartis Venture Funds

Photo of Christine Brennan, Principal at Novartis Venture Funds

Novartis Venture Funds

Photo of David Morris, Venture Partner at Novartis Venture Funds

Novartis Venture Funds